Allergan’s Botox Patent Dispute Advances to July Trial in Delaware

Allergan’s ongoing legal battle over Botox patents is set to proceed to trial this July in Delaware. This development comes after a federal judge dismissed the summary judgment motions presented by the involved parties. The lawsuit, which involves allegations against two biotechnology companies for patent infringement concerning Botox products, marks a significant phase in Allergan’s legal pursuits. For further insights, access the full briefing on Law360. This case highlights the heightened legal scrutiny and complexities surrounding intellectual property rights in the competitive biotechnology and pharmaceutical sectors.